MarketCap
Air Products and Chemicals APD
$ 301.27
0.03%
Facebook
X
Telegram
Air Products and Chemicals Financial Ratios 2025-2006 | APD
Brief overview of Air Products and Chemicals's multiples and efficiency
Current figures are compared with the company's own five-year history for 2020–2024.
The latest available valuation ratios are P/E 19.1x (median 26.43x), EV/EBITDA 16.76x (median 15.01x), P/S 4.66x (median 5.04x). On average, multiples differ from their five-year medians by only -7.6%. Valuation is near its familiar historical range.
Earnings yield calculated as 1/P/E is about 5.2%, showing current profit per unit of share price.
End-period return metrics are ROE -2.6%, ROA -1%, ROCE -2.5%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
The cash cycle accelerated by 10.7 days to 26.7 days. Less capital is tied up in operations.
What the ratios show
Air Products and Chemicals's profile looks neutral, with price and fundamental efficiency broadly aligned.
Annual Financial Ratios Air Products and Chemicals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-142.2 | 19.1 | 26.4 | 30.3 | 24.8 | 29.2 | 26.2 | 22.5 | 11.6 | 45.9 | 21.6 | 26.5 | 20.9 | 13.0 | 14.4 | 49.3 | 52.5 | 287.3 | 15.2 | - |
P/S |
4.7 | 6.0 | 4.8 | 5.4 | 5.0 | 6.2 | 5.2 | 3.8 | 4.3 | 3.0 | 2.8 | 2.5 | 2.0 | 1.6 | 1.7 | - | - | - | - | - |
EPS |
-1.8 | 17.2 | 10.3 | 10.2 | 9.5 | 8.5 | 8.0 | 6.8 | 13.8 | 2.9 | 6.0 | 4.7 | 4.7 | 5.5 | 5.8 | 1.2 | 1.2 | 0.3 | 4.8 | - |
EV (Enterprise Value) |
78 B | 91 B | 75.5 B | 79.1 B | 60.4 B | 62.5 B | 51.4 B | 38.9 B | 39.9 B | 38.5 B | 37.5 B | 36.2 B | 31 B | 25.1 B | 25.5 B | 20.7 B | 20.8 B | 27 B | 15.7 B | -31 M |
EBITDA per Share |
3.09 | 26.6 | 17.3 | 16.6 | 16.3 | 15.5 | 14.6 | 13.4 | 12 | 14.4 | 13.1 | 12.2 | 11.6 | 7.21 | 11.4 | 5.46 | 5.65 | 4.63 | 10 | - |
EV/EBITDA |
113.4 | 15.4 | 19.6 | 21.5 | 16.8 | 18.8 | 15.0 | 11.8 | 13.6 | 10.8 | 11.8 | 12.3 | 10.9 | 13.2 | 9.0 | 17.8 | 17.6 | 27.5 | 7.2 | - |
PEG |
30.29 | 1.35 | 4.95 | 4.46 | 8.04 | 7.27 | 6.08 | -0.45 | 0.03 | -0.9 | 0.78 | -15.7 | -1.46 | -3.41 | 0.78 | - | - | - | - | - |
P/B |
3.2 | 3.9 | 3.9 | 5.0 | 3.7 | 4.4 | 4.0 | 3.0 | 3.4 | 4.0 | 3.7 | 3.5 | 2.9 | 2.3 | 3.0 | 2.3 | 2.7 | 3.8 | - | - |
P/CF |
- | - | - | - | - | - | - | 34.6 | 66.0 | 18.4 | 33.6 | 52.3 | 481.4 | 54.8 | 43.9 | 8.7 | 10.0 | 11.9 | 10.5 | - |
ROE % |
-2.63 | 22.47 | 16.07 | 17.16 | 14.90 | 15.16 | 15.45 | 13.40 | 29.46 | 8.75 | 17.31 | 13.19 | 13.81 | 17.62 | 20.61 | 4.84 | 5.25 | 1.36 | 18.84 | - |
ROA % |
-0.96 | 9.67 | 7.19 | 8.30 | 7.82 | 7.50 | 9.29 | 7.81 | 16.25 | 3.50 | 7.33 | 5.58 | 5.57 | 6.89 | 8.57 | 1.99 | 1.93 | 0.55 | - | - |
ROCE % |
-2.54 | 13.23 | 9.32 | 10.09 | 9.48 | 9.83 | 12.52 | 11.65 | 10.90 | 14.77 | 13.61 | 11.07 | 10.48 | 10.66 | 12.95 | 2.98 | 3.32 | 1.12 | 25.03 | - |
Current Ratio |
1.7 | 1.9 | 2.0 | 2.0 | 2.1 | 2.0 | 2.5 | 2.2 | 2.4 | 1.3 | 0.8 | 1.1 | 1.1 | 1.3 | 1.4 | 1.7 | 1.6 | 1.7 | - | - |
DSO |
56.4 | 53.1 | 50.6 | 46.6 | 48.2 | 52.2 | 50.5 | 62.0 | 68.7 | 69.3 | 65.3 | 66.8 | 70.6 | 73.1 | 67.4 | - | - | - | - | - |
DIO |
34.1 | 31.7 | 24.1 | 18.9 | 21.8 | 24.7 | 24.0 | 23.4 | 21.3 | 35.3 | 34.6 | 33.8 | 34.5 | 40.7 | 34.0 | 31.4 | 30.6 | 11.9 | - | - |
DPO |
63.9 | 59.5 | 48.2 | 36.3 | 32.6 | 33.2 | 34.0 | 35.1 | 41.8 | 38.5 | 33.6 | 35.4 | 50.1 | 52.0 | 81.9 | 98.0 | 50.6 | - | - | - |
Operating Cycle |
90.5 | 84.8 | 74.7 | 65.6 | 70.0 | 77.0 | 74.5 | 85.3 | 89.9 | 104.6 | 99.9 | 100.5 | 105.0 | 113.8 | 101.4 | 31.4 | 30.6 | 11.9 | - | - |
Cash Conversion Cycle |
26.7 | 25.3 | 26.5 | 29.3 | 37.4 | 43.8 | 40.4 | 50.2 | 48.1 | 66.1 | 66.3 | 65.1 | 55.0 | 61.8 | 19.5 | -66.6 | -20.0 | 11.9 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Air Products and Chemicals
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-6.47 | 3.19 | 3.04 | 3.04 | 3.2 | 3.2 | -7.77 | 2.77 | 3.13 | 3.13 | 2.57 | 2.74 | 2.68 | 2.68 | 1.98 | 2.58 | - | 2.62 | 2.39 | 2.53 | - | 2.41 | 2.13 | 2.18 | 2.2 | 2.02 | 2.18 | 2.15 | 2.28 | 2.21 | 2.15 | 1.58 | 2.06 | 2.16 | 1.58 | 0.71 | 2.15 | 0.47 | 0.71 | 1.38 | 1.81 | 1.6 | 1.38 | 1.68 | 1.6 | 1.48 | 1.68 | 1.52 | 0.49 | 1.47 | 1.52 | 1.37 | 0.65 | 1.38 | 1.37 | 1.33 | 0.66 | 2.29 | 1.33 | 1.18 | 1.54 | 1.54 | 1.18 | 1.19 | 1.19 | 1.19 | 0.54 |
EBITDA per Share |
-4.34 | 6.73 | 4.96 | 4.96 | 8.72 | - | - | 4.54 | 8.13 | - | - | 4.57 | 7.4 | - | - | 4.38 | - | 2.83 | 2.53 | 3.85 | - | 5.55 | 2.48 | 3.9 | 6.48 | 5.08 | 3.9 | 3.85 | 6.31 | 4.94 | 3.85 | 3.24 | 5.68 | 4.48 | 3.24 | 3.15 | 5.01 | 3.1 | 3.15 | 2.45 | 4.78 | 3.8 | 2.45 | 2.72 | 4.98 | 3.55 | 3.36 | 2.61 | 3.98 | 4.12 | 3.11 | 2.93 | 4.08 | 3.95 | 2.93 | 2.81 | 3.69 | 4.21 | 2.81 | 2.65 | 4.79 | 3.78 | 2.84 | 4.64 | 3.65 | 2.66 | 3.62 |
ROE % |
2.96 | 17.93 | 17.99 | 1.82 | 0.71 | 0.73 | 0.31 | 15.59 | 16.07 | 15.67 | 15.37 | 14.86 | 15.02 | 14.90 | 14.69 | 15.59 | 11.65 | 15.73 | 15.13 | 15.27 | 11.37 | 15.40 | 15.02 | 15.52 | 15.83 | 16.35 | 17.07 | 17.39 | 16.46 | 16.08 | 16.03 | 14.93 | 13.25 | 13.73 | 10.37 | 8.70 | 11.38 | 12.29 | 16.18 | 18.88 | 19.63 | 18.82 | 18.32 | 19.10 | 18.58 | 15.24 | 15.11 | 14.50 | 14.08 | 14.61 | 14.44 | 14.16 | 14.58 | 14.78 | 18.16 | 18.34 | 18.12 | 21.58 | 19.73 | 19.72 | 20.36 | 19.54 | 18.91 | 16.92 | 4.79 | 5.00 | 2.30 |
ROA % |
1.43 | 6.71 | 6.72 | 0.62 | 0.52 | 0.69 | 0.86 | 6.90 | 7.15 | 7.19 | 7.23 | 7.13 | 7.37 | 7.38 | 7.52 | 8.05 | 6.03 | 6.03 | 7.79 | 7.71 | 5.64 | 7.58 | 7.32 | 7.47 | 8.04 | 8.77 | 9.57 | 10.16 | 9.56 | 9.26 | 9.15 | 8.45 | 7.48 | 7.66 | 5.75 | 4.78 | 5.81 | 5.45 | 6.83 | 7.65 | 7.88 | 7.68 | 7.60 | 8.03 | 7.77 | 6.37 | 6.29 | 6.02 | 5.80 | 5.98 | 5.83 | 5.63 | 5.61 | 5.66 | 6.90 | 6.92 | 7.05 | 8.50 | 7.92 | 8.02 | 8.24 | 7.88 | 7.55 | 6.74 | 1.92 | 1.95 | 0.92 |
ROCE % |
-0.05 | 8.55 | 8.72 | -0.73 | -0.98 | -0.88 | -0.89 | 8.48 | 8.81 | 8.92 | 9.04 | 8.77 | 9.22 | 11.13 | 11.07 | 11.47 | 8.87 | 11.36 | 9.28 | 9.33 | 7.20 | 9.70 | 9.62 | 9.69 | 10.53 | 11.62 | 12.61 | 13.54 | 13.08 | 12.72 | 12.45 | 11.86 | 11.94 | 11.59 | 10.10 | 10.24 | 9.95 | 9.75 | 10.82 | 10.16 | 10.37 | 10.41 | 9.88 | 11.27 | 10.80 | 9.09 | 9.80 | 9.15 | 9.58 | 9.85 | 9.69 | 9.43 | 9.41 | 9.29 | 10.09 | 10.07 | 10.36 | 12.56 | 12.32 | 12.86 | 16.32 | 19.44 | 23.01 | 22.67 | 6.47 | 6.85 | 2.92 |
Current Ratio |
1.7 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.8 | 1.9 | 1.8 | 1.8 | 1.8 | 1.9 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | - | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.0 | 2.0 | 2.0 | 2.0 | 2.5 | 2.5 | 2.5 | 2.5 | 2.4 | 2.4 | 2.4 | 2.4 | 2.3 | 2.2 | 2.2 | 2.2 | 1.8 | 1.7 | 1.7 | 1.7 | 1.8 | 1.7 | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
DSO |
55.1 | 55.1 | 55.7 | 56.5 | 58.7 | 57.2 | 57.2 | 54.8 | 52.3 | 52.4 | 53.6 | 55.7 | 58.2 | 54.9 | 50.5 | 52.0 | - | 24.7 | 53.0 | 47.9 | - | 50.3 | 52.4 | 51.8 | 50.1 | 56.3 | 49.2 | 51.6 | 50.4 | 51.7 | 51.2 | 50.8 | 47.9 | 48.8 | 51.6 | 49.5 | 48.6 | 50.5 | 51.5 | 53.5 | 53.8 | 54.6 | 59.0 | 59.0 | 58.9 | 66.3 | 54.9 | 65.2 | 50.6 | 51.5 | 54.3 | 55.7 | 54.5 | 55.3 | 54.7 | 54.4 | 54.1 | 60.2 | 54.7 | 56.8 | 49.6 | 54.2 | 56.3 | - | - | - | - |
DIO |
32.6 | 32.5 | 34.1 | 34.3 | 35.7 | 35.0 | 33.5 | 33.8 | 34.4 | 33.6 | 32.8 | 30.3 | 29.3 | 28.9 | 25.6 | 23.1 | - | 9.9 | 21.1 | 19.3 | - | 22.8 | 22.9 | 23.1 | 8.6 | 27.5 | 22.5 | 24.2 | 7.9 | 24.2 | 24.3 | 23.6 | 7.8 | 23.4 | 22.0 | 19.8 | 7.3 | 20.6 | 19.3 | 20.3 | 6.1 | 17.6 | 31.9 | 33.6 | 8.2 | 35.0 | 39.0 | 35.3 | 11.3 | 33.6 | 34.9 | 34.2 | 11.5 | 34.4 | 35.5 | 36.8 | 14.0 | 42.5 | 35.8 | 36.4 | 11.7 | 33.8 | 30.4 | 28.4 | 28.8 | 29.6 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.1 | - | - | - | 15.3 | 5.8 | - | - | 16.2 | 5.4 | - | - | 17.6 | 5.9 | - | - | 19.1 | 7.2 | - | - | 20.1 | 6.9 | - | - | 18.6 | 4.6 | - | - | 18.4 | 5.9 | - | - | 25.1 | 8.4 | - | - | 24.1 | 8.9 | - | - | 21.0 | 6.9 | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 90.8 | - | 92.2 | 90.7 | 88.6 | - | 86.0 | 86.3 | 86.0 | - | 83.7 | 76.1 | 75.1 | - | 34.6 | 74.1 | 67.2 | - | 73.1 | 75.3 | 74.9 | 58.8 | 83.8 | 71.8 | 75.8 | 58.3 | 75.9 | 75.5 | 74.4 | 55.7 | 72.2 | 73.6 | 69.4 | 55.9 | 71.1 | 70.9 | 73.8 | 59.8 | 72.3 | 90.9 | 92.6 | 67.1 | 101.3 | 94.0 | 100.5 | 62.0 | 85.0 | 89.2 | 89.9 | 66.0 | 89.7 | 90.2 | 91.2 | 68.1 | 102.7 | 90.5 | 93.2 | 61.2 | 88.0 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | 90.8 | - | 92.2 | 90.7 | 88.6 | - | 86.0 | 86.3 | 86.0 | - | 83.7 | 76.1 | 75.1 | - | 34.6 | 74.1 | 52.1 | - | 73.1 | 75.3 | 59.6 | 52.9 | 83.8 | 71.8 | 59.6 | 52.9 | 75.9 | 75.5 | 56.8 | 49.9 | 72.2 | 73.6 | 50.2 | 48.8 | 71.1 | 70.9 | 53.8 | 52.9 | 72.3 | 90.9 | 74.0 | 62.5 | 101.3 | 94.0 | 82.0 | 56.0 | 85.0 | 89.2 | 64.8 | 57.6 | 89.7 | 90.2 | 67.0 | 59.1 | 102.7 | 90.5 | 72.2 | 54.3 | 88.0 | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Air Products and Chemicals, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
China
USA
Brasil
Canada
Chile
